Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
68.98
+1.03 (1.52%)
At close: Aug 13, 2025, 4:00 PM
69.00
+0.02 (0.03%)
After-hours: Aug 13, 2025, 6:21 PM EDT
Hologic Revenue
Hologic had revenue of $1.02B in the quarter ending June 28, 2025, with 1.23% growth. This brings the company's revenue in the last twelve months to $4.04B, up 1.29% year-over-year. In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B, down -0.00%.
Revenue (ttm)
$4.04B
Revenue Growth
+1.29%
P/S Ratio
3.90
Revenue / Employee
$571,839
Employees
7,063
Market Cap
15.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
| Sep 28, 2019 | Pro | Pro | Pro |
| Sep 29, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 24, 2016 | Pro | Pro | Pro |
| Sep 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
HOLX News
- 14 days ago - Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Hologic raises annual profit forecast on diagnostic and surgical demand - Reuters
- 14 days ago - Hologic Announces Financial Results for Third Quarter of Fiscal 2025 - Business Wire
- 22 days ago - Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy - Seeking Alpha
- 6 weeks ago - Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 - Business Wire
- 2 months ago - Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation - Business Wire
- 2 months ago - Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? - Benzinga
- 2 months ago - Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports - Reuters